← SynDRA
SOTAGLIFLOZIN
SynDRA canonical compound SYN0037754 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC5A2 |
|---|
| Mechanism of action | Sodium/glucose cotransporter inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Sodium/glucose cotransporter inhibitor
- SLC5A1 INHIBITOR
- Sodium/glucose cotransporter 1 inhibitor
- SLC5A2 INHIBITOR
- Sodium/glucose cotransporter 2 inhibitor
- SLC5A2 MODULATOR
Drug classes
- Hypoglycemic Agents
- Sodium-Glucose Transporter 2 Inhibitors
- P-Glycoprotein Inhibitors
- Sodium-Glucose Cotransporter 2 Inhibitor
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- zynquista
- LP-802034
- LX4211
- LX-4211
- inpefa
- Sotagliflozine
- Sotagliflozina
- Inpefa
- Sar-439954
- Sar439954
- Zynquista
- LX 4211
- UNII-6B4ZBS263Y
- 6B4ZBS263Y
- AK170751
- (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol
- b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-;b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
- Sotagliflozin [USAN:INN]
- beta-l-Xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, (5S)-
- Tube103
- LP 802034
- INPEFA
- sotagliflozina
- sotagliflozine
- sotagliflozinum
- RefChem:57075
- DTXCID7066805
- A10BK06
- MFCD22493506
- C21H25ClO5S
- Inpefa (TN)
- SOTAGLIFLOZIN [MI]
- Sotagliflozin (LX4211)
- SOTAGLIFLOZIN [INN]
- Sotagliflozin (USAN/INN)
- SOTAGLIFLOZIN [USAN]
- Sotagliflozin (LX-4211)
- Sotagliflozin (LX-4211)?
Look up SOTAGLIFLOZIN in the interactive SynDRA portal →